U.S. Professional Services Stock News

Graham Holdings recently reported mixed quarterly results, with revenue growth in education, healthcare, and manufacturing offset by weaker performance in television broadcasting and automotive, and completed the purchase of Covenant Home Health to build out its residential home health offerings. Kaplan’s new partnership with South Carolina State University to provide free exam preparation highlights how Graham Holdings is using education services and healthcare expansion to diversify beyond...

In recent days, J.B. Hunt Transport Services announced plans for a dual listing on the newly launched Nasdaq Texas exchange to broaden its access to capital while reinforcing its presence in a key U.S. logistics hub. The company also highlighted its logistics strengths by securing recognition as Best Overall Intermodal Provider for the sixth consecutive time in a JOC survey, underscoring its competitive position in the intermodal freight market. Next, we’ll examine how the planned Nasdaq...

In early April 2026, UMH Properties’ board declared past quarterly cash dividends of US$0.225 per common share and US$0.3984375 per Series D preferred share, both payable on June 15, 2026, to shareholders of record on May 15, 2026. Alongside these payouts, UMH reported converting 146 homes from inventory to rentals and lifting rental occupancy to 94.6%, highlighting improving asset utilization and income potential from its manufactured housing portfolio. We’ll now examine how UMH’s higher...

Why analyst sentiment and sector outperformance are drawing attention Recent upgrades to full-year earnings estimates and a favorable Zacks Rank have put Capital Southwest (CSWC) on the radar. The stock has also outpaced broader Finance sector returns so far this year. See our latest analysis for Capital Southwest. At a share price of US$22.37, Capital Southwest has seen a 2.0% 1 day share price return and a 4.1% 7 day share price return. Its 1 year total shareholder return of 34.5% and 3...

Tarsus Pharmaceuticals has already dosed the first participant in its Phase 2 Calliope trial of TP-05, an oral lotilaner-based therapy being tested in about 700 at-risk adults across U.S. Lyme-endemic regions, where no FDA-approved drug prophylaxis currently exists. This move extends Tarsus beyond eye-care into infectious disease prevention, targeting a large U.S. population considered at moderate to high risk for Lyme disease. We’ll now examine how TP-05’s Phase 2 progress, as a potential...

Flood-related washout puts CSX’s rail resilience in focus A flood-related washout near Coloma has shut a CSX (CSX) owned line between Chicago and Grand Rapids, disrupting freight and Amtrak passenger traffic and putting short term operational risk and repair costs on investors’ radar. See our latest analysis for CSX. CSX’s share price has climbed 13.7% year to date and the 1 year total shareholder return of 54.5% points to strong momentum, even as short term events like the Coloma washout...

Earnings pop puts Universal Display’s latest move in focus Universal Display (OLED) recently reported financial results that featured strong revenue growth and a small earnings miss, yet the stock climbed nearly 16% as investors reacted to the company’s commentary and capital allocation plans. See our latest analysis for Universal Display. That earnings reaction sits against a tougher backdrop, with a 90 day share price return showing a 29.02% decline and a 1 year total shareholder return...

NVIDIA Corporation and Marvell Technology, Inc. recently announced a wide-ranging partnership that links Marvell’s custom XPUs and networking to NVIDIA’s NVLink Fusion AI factory and AI-RAN ecosystems, alongside NVIDIA’s US$2.00 billion purchase of Marvell Series A Convertible Preferred Stock. This combination of deep product integration and equity investment ties Marvell more closely into NVIDIA’s AI roadmap, potentially reshaping Marvell’s role in next-generation data center and telecom...

Aspect and Five9 (FIVN) have formalized a partnership that connects Five9’s real-time and historical interaction data with Aspect’s workforce management tools. The move is aimed at more precise staffing, forecasting, and contact center cost control. See our latest analysis for Five9. Despite this new partnership focused on improving contact center efficiency, Five9’s 30 day share price return of 17.03% and year to date share price return of 20.20% declines, alongside a 1 year total...

Investor reaction to INLIGHT Phase 1 update Wave Life Sciences (WVE) shares sold off after the company released new interim data from the Phase 1 INLIGHT trial of its obesity candidate WVE-007, with results falling short of market expectations. The update highlighted clinically meaningful reductions in visceral fat and waist circumference. However, investor response reflected concerns about how these findings compare with existing obesity treatments and what that might imply for future...

Why Hewlett Packard Enterprise’s latest plan change and AI push matter for shareholders Hewlett Packard Enterprise (HPE) recently drew investor attention after shareholders approved a 22 million share increase to its 2021 Stock Incentive Plan, alongside fresh AI and security product launches with partners including NVIDIA. This mix of equity compensation changes and new AI focused offerings gives you a fresh set of data points to think about how HPE is trying to keep key talent, compete in...

Cboe Global Markets plans to introduce 24-hour, 5-days-per-week trading for U.S. equities on its EDGX exchange, pending regulatory review. The move would extend U.S. stock trading to an around-the-clock schedule on weekdays, aligning more closely with global trading hours. The initiative is aimed at giving investors continuous access to U.S. equities and could influence liquidity patterns and competition across trading venues. Cboe Global Markets (BATS:CBOE) is pursuing this expanded...

Why World Kinect is on investors’ radar today World Kinect (WKC) is drawing fresh attention after recent share price moves left the stock showing a month return of about 4% and a past 3 months decline of roughly 10%. For investors tracking energy management names, this shift in performance is prompting a closer look at how World Kinect’s diversified Aviation, Land, and Marine operations align with its current valuation and recent financial profile. See our latest analysis for World...

In March 2026, Fidelity National Financial, Inc. appointed Jeffrey Heighton as President of Enterprise Solutions – Agency to work with title agents on growth, financial performance, and technology-driven operational scale. This hire expands FNF’s consultative model for its agency network, deepening support around revenue strategy, expense management, and back-office optimization. Next, we’ll examine how AI-driven downgrades tied to weakening cash flow and profitability pressures may...

Wolfe Research’s new coverage of BeOne Medicines (NasdaqGS:ONC), paired with recent FDA orphan drug designation for its hepatocellular carcinoma treatment, has pushed this oncology group back into focus for biotech investors. See our latest analysis for BeOne Medicines. After a strong run, with a 7 day share price return of 9.4% and a 1 year total shareholder return of 40.92%, recent coverage initiations and the FDA orphan drug designation appear to have reinforced interest following earlier...

Why Loma Negra’s amended share pledge matters now Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) recently announced an amended and restated share pledge linked to controlling shareholder InterCement’s court approved reorganization plan, clarifying its own exclusion from the judicial process and confirming its ongoing normal operations. See our latest analysis for Loma Negra Compañía Industrial Argentina Sociedad Anónima. At a share price of $11.07, Loma Negra has a 7 day...

Recent slowdown in growth and returns puts Simpson Manufacturing under the spotlight Simpson Manufacturing (SSD) is back on investors’ radar after fresh analysis flagged a clear slowdown in annualized revenue growth, a decline in earnings per share, and a drop in return on invested capital, all pointing to cooler momentum. See our latest analysis for Simpson Manufacturing. At a share price of $166.30, Simpson Manufacturing has seen a 10.6% 1 month share price decline and a 2.3% 3 month share...

Over the last 7 days, the United States market has risen by 3.5%, and in the last year, it has climbed an impressive 31%, with earnings expected to grow by 16% per annum over the next few years. In this dynamic environment, identifying high growth tech stocks that align with these positive market trends can be key to achieving potential portfolio gains.

Over the last 7 days, the United States market has risen by 3.5%, contributing to a remarkable 31% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, identifying stocks that are potentially undervalued can offer investors opportunities to capitalize on price discrepancies relative to their intrinsic value.

In the past week, the United States market has experienced a 3.5% increase and boasts a remarkable 31% rise over the last year, with earnings projected to grow by 16% annually. In such an environment, stocks with high insider ownership can be particularly appealing as they often indicate confidence from those closest to the company's operations and potential for promising growth.

The United States market has shown robust growth, rising 3.5% over the last week and 31% over the past year, with earnings expected to increase by 16% annually in the coming years. In such a thriving market, identifying stocks with strong financials becomes crucial for investors seeking both affordability and growth potential. Although often considered a term from bygone eras, penny stocks continue to offer intriguing opportunities within smaller or newer companies that might surprise...

The United States market has shown impressive strength, rising 3.5% over the last week and climbing 31% over the past year, with earnings projected to grow by 16% annually. In such a robust environment, identifying lesser-known stocks with strong fundamentals and growth potential can offer intriguing opportunities for investors seeking to diversify their portfolios.

The market in the United States has shown a notable uptick, rising 3.5% over the last week and achieving a 31% increase over the past year, with earnings projected to grow by 16% annually. In such an environment, dividend stocks that offer consistent payouts and potential for growth can be appealing options for investors seeking to benefit from both income and capital appreciation.

In recent days, GeneDx Holdings faced weakening sentiment as bearish technical signals and mixed analyst views coincided with institutional investors reducing their exposure to the company. This divergence between institutional outflows and lingering retail optimism highlights a growing disconnect in how different investor groups interpret GeneDx’s prospects. We’ll now examine how institutional caution and shifting sentiment could influence GeneDx’s existing investment narrative built around...